|
Name |
Oleic acid, 3-(octadecyloxy)propyl ester
|
| Molecular Formula | C39H76O3 | |
| IUPAC Name* |
3-octadecoxypropyl (Z)-octadec-9-enoate
|
|
| SMILES |
CCCCCCCCCCCCCCCCCCOCCCOC(=O)CCCCCCC/C=C\CCCCCCCC
|
|
| InChI |
InChI=1S/C39H76O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-36-41-37-34-38-42-39(40)35-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h18,20H,3-17,19,21-38H2,1-2H3/b20-18-
|
|
| InChIKey |
DGJSXVYZCNEXGC-ZZEZOPTASA-N
|
|
| Synonyms |
17367-41-8; Oleic acid 3-(octadecyloxy)propyl ester; 3-octadecoxypropyl (Z)-octadec-9-enoate; (Z)-9-Octadecenoic acid 3-(octadecyloxy)propyl ester; Oleic acid, 3-(octadecyloxy)propyl ester; 3-(Octadecyloxy)propyl (9E)-9-octadecenoate #
|
|
| CAS | NA | |
| PubChem CID | 21159937 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 593.0 | ALogp: | 16.6 |
| HBD: | 0 | HBA: | 3 |
| Rotatable Bonds: | 37 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 35.5 | Aromatic Rings: | 0 |
| Heavy Atoms: | 42 | QED Weighted: | 0.033 |
| Caco-2 Permeability: | -5.274 | MDCK Permeability: | 0.00000496 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.277 |
| 30% Bioavailability (F30%): | 1 |
| Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 103.39% |
| Volume Distribution (VD): | 4.089 | Fu: | 0.43% |
| CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.119 |
| CYP2C19-inhibitor: | 0.09 | CYP2C19-substrate: | 0.041 |
| CYP2C9-inhibitor: | 0.02 | CYP2C9-substrate: | 0.929 |
| CYP2D6-inhibitor: | 0.052 | CYP2D6-substrate: | 0.011 |
| CYP3A4-inhibitor: | 0.18 | CYP3A4-substrate: | 0.011 |
| Clearance (CL): | 4.556 | Half-life (T1/2): | 0.053 |
| hERG Blockers: | 0.959 | Human Hepatotoxicity (H-HT): | 0.008 |
| Drug-inuced Liver Injury (DILI): | 0.058 | AMES Toxicity: | 0.006 |
| Rat Oral Acute Toxicity: | 0.014 | Maximum Recommended Daily Dose: | 0.017 |
| Skin Sensitization: | 0.989 | Carcinogencity: | 0.023 |
| Eye Corrosion: | 0.542 | Eye Irritation: | 0.898 |
| Respiratory Toxicity: | 0.723 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001842 | ![]() |
0.905 | D00AOJ | ![]() |
0.484 | ||
| ENC001705 | ![]() |
0.766 | D0O1PH | ![]() |
0.400 | ||
| ENC000741 | ![]() |
0.677 | D0Z1QC | ![]() |
0.395 | ||
| ENC000443 | ![]() |
0.648 | D01NTX | ![]() |
0.382 | ||
| ENC000437 | ![]() |
0.646 | D00STJ | ![]() |
0.378 | ||
| ENC000381 | ![]() |
0.644 | D00FGR | ![]() |
0.366 | ||
| ENC000576 | ![]() |
0.640 | D07ILQ | ![]() |
0.356 | ||
| ENC000436 | ![]() |
0.638 | D05ZPL | ![]() |
0.324 | ||
| ENC000438 | ![]() |
0.638 | D00MLW | ![]() |
0.318 | ||
| ENC000435 | ![]() |
0.627 | D0Z5SM | ![]() |
0.311 | ||